Public Health alert: Latest Canada COVID-19 reports, from the Canadian Chief Public Health Officer on April 14, 2021

Posted by

Introduction

The case of coronavirus disease has been an ongoing issue and a major public health concern. Recently we published an article on the global updates of COVID-19. However, this problem is somewhat still needing some further investigations. Thus the Canadian public health alert. Therefore, today we will be sharing the latest Canadian coronavirus report from the public health agency Canada.

Canada public health alert
Latest coronavirus Report from the Canadian prime minister

On this day, April 14, 2021, Ottawa, ON Public Health Agency of Canada shared thus;

The COVID-19 pandemic continues to create stress and anxiety for many citizens of Canada, public health alert index. More especially those who do not have ready access to their regular support networks. With the help of the Wellness Together Canada online portal. People of all ages across the country can access immediate, free and confidential mental health and substance use supports, 24 hours a day, seven days a week.

Details from the Canadian Public Health Agency

The Public Health Agency of Canada (PHAC) has received a report of a case of an individual in Canada who has experienced a very rare but serious medical event. Which involves blood clots (thrombosis) with low levels of blood platelets (thrombocytopenia). As a result of immunization with COVISHIELD (the Serum Institute of India version of the AstraZeneca COVID-19 vaccine).

Meanwhile, this is the first reported case of this rare adverse event in Canada. Global evidence indicates that reports of blood clots with low platelets in people following a shot of the AstraZeneca COVID-19 vaccine are very rare.

Moreover, these rare adverse events were first motioned as a possible safety issue in March 2021 in Europe. Health Canada has been working with international regulators and AstraZeneca manufacturers to review emerging data and evidence.

Furthermore, as for precaution measures, Health Canada and international regulators are assessing information relating to these reports in Europe. More so, the National Advisory Committee on Immunization (NACI) and the Chief Medical Officers of Health recommended a pause. In the use of the AstraZeneca COVID-19 vaccine in all individuals less than 55 years of age in Canada.

Today, Health Canada updated the AstraZeneca and COVISHIELD COVID-19 vaccine labeling information. Also requested the manufacturer’s risk management plan updates for the AstraZeneca vaccine. Looking at all the recent available evidence globally, Health Canada considers that the benefits of AstraZeneca. As will as COVISHIELD vaccines, in protecting against the severe outcomes of COVID-19, continue to outweigh the potential risks.

As information emerges from Health Canada’s ongoing assessment, including information on the adverse event reported in Canada. The NACI will consider these findings and assess its recommendation in the broader public health context.

Detection and timely reporting of the first case of blood clots with low levels of blood platelets following immunization with COVISHIELD in Canada. This shows that our vaccine safety monitoring system is working. Meanwhile, it is part of the ongoing global vaccine safety monitoring system.

Coronavirus Canadian updates
Canadian Covid-19 statistical analysis

The monitoring teams are very alert

Collaboratively, Health Canada, PHAC, NACI, and the Chief Medical Officers of Health are working with experts across the country. With those around the world to often review the evolving evidence in the Canadian context. Also to alert health care professionals and the public on symptoms to be aware of that can aid in quick detection and treatment available to tackle this event.

Additionally, as COVID-19 activity proceeds in Canada, we are tracking a range of epidemiological indicators. This is to rectify where the disease is most active. Also the prevalence and how it is impacting the health of Canadians. As well as the public health,  laboratories, and healthcare capacity.

Consequently, the Public Health Agency of Canada is providing Canadians with regular updates on COVID-19 vaccines administered. Also its coverage, and ongoing monitoring of vaccine safety across the country.

The following is the latest summary of national numbers and trends. As well as the actions we all need to be taking to reduce infection rates, while vaccination programs expand for the protection of all Canadians. 

 Meanwhile, from the onset of the pandemic, there have been 1,078,562 cases of COVID-19. This includes 78,293 active cases and 23,392 deaths reported in Canada. Subsequently, these cumulative numbers tell us about the overall burden of COVID-19 illness to date.

Canada public health alert
COVID-19 Epidemiology from the Canadian’s point of view

Important information about the  vaccination

They equally tell us, together with results of serological studies, that the vast majority of Canadians are still susceptible to COVID-19. As vaccine delivery ramps up at an accelerated pace, there is cause for optimism that widespread. Until lasting immunity is achieved through COVID-19 vaccination. 

Importantly, we now have multiple safe and effective COVID-19 vaccines. Which has unique advantages that are authorized for Canadians useVaccine coverage is increasing across the country with benefits being seen in prioritized high-risk populations.

Ramp up of vaccine supply and acceleration of vaccination programs will return further benefits. To protect more Canadian over the coming weeks and months.

However, with the recent acceleration of COVID-19 activity and a worrying rise in the percentage of cases that involve more contagious variants of concern. Strong public health measures and individual precautions must be sustained where COVID-19 is circulating.

The overwhelming prevalence of COVID-19

The recent national-level data shows that corona prevalence is a public health alert. With a 7-day average of 8,238 new cases daily (April 7 to 13). Sustained high infection rates are also impacting COVID-19 severity indicators. More especially in areas with increased disease activity.

The increase in severe and critical illnesses is placing revived strain on the health system and healthcare workforce. Provincial and territorial data indicate that about 3,206 people with COVID-19 are being treated in Canadian hospitals each day during the most recent 7-day period (April 7 to 13). Confirming a 33% increase over last week.

This includes an average of 993 people who were being treated in intensive care units (ICU). This is a 23% increase than last week, exceeding the peak treated in ICUs daily during the first and second waves.

If the elevation in severe illnesses persists, the concern is that we could see a gradual increase in the mortality trend. Over the past week, there was an average of 36 deaths reported daily, which is 17% higher than last week.

Impact of coronavirus
The terrible impacts of coronavirus on Canadians and globally can never be overemphasized

The terrible impact of COVID-19 on  Canadians

Furthermore, as COVID-19 continues to impact people of all ages in Canada, infection rates are highest among those aged 20 to 39 years of age. As we are seeing an increased number of adults under the age of 60 years being treated for COVID-19 in hospital, including in ICUs.

This serves as a reminder that serious illness can occur at any age. As indicated by evidence that variants of concern can be associated with more severe illness and increased risk of death. Moreover, the circulation of COVID-19 in younger, more mobile, and socially connected adults is ongoing.

Also, the risk for spread into high-risk populations and settings and several jurisdictions have highlighted social gatherings as an important driver for spread. As of April 13, a total of 41,818 variant of concern cases have been reported across Canada. This includes 39,663 involving B.1.1.7 variants, 1,780 P.1, and 375 B.1.351 variants.

Although B.1.1.7, continues to account for the majority of variants of concern in Canada and has likely replaced the original virus in some areas, there has been a concerning rise in P.1 cases in recent weeks. The first evidence implies that the P.1 variant may reduce the effectiveness of vaccines, making it even more important to control its spread.

Canadians are urged to remain vigilant, continue following local public health advice. Consistently maintain individual practices that keep us and our families safer. Endeavor to stay home/self-isolate if you have any symptoms, think about the risks and reduce non-essential activities and outings.

Also, avoid all non-essential travel, and maintain individual protective practices of physical distancing, hand, cough. Additionally, maintain surface hygiene by wearing a well-fitted and properly worn face mask as appropriate. Including in shared apartments, indoors or outdoors, with people from outside of your immediate household.

Conclusion statement

Canadians can also go the extra mile by sharing reasonable information on COVID-19 risks and prevention practices. As well as measures to reduce COVID-19 in communities and by downloading the COVID Alert app to break the cycle of infection and help limit the spread of COVID-19.

The Canada public health alert: prevalence of coronavirus
Canadian covid updates show that the prevalence is still overwhelming

In conclusion, the fear of coronavirus disease is still overwhelming globally. With the continuous increase of the cases regardless of the distribution of its vaccine. Thus, global public health alert. Meanwhile, today we discussed this using the report obtained from the Canadian public health agency.

Many thanks for your time. Always feel free to come around and get more updates.

Cheers! Admin.

Leave a Reply

Your email address will not be published. Required fields are marked *